CLINICAL_TRIALS
trial_result
· 2012-02-27
Clinical Trial Update: Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC) [Phase 2]
Summary
A Phase 2 trial of thalidomide for primary sclerosing cholangitis was terminated, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mayo Clinic | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: TERMINATED | Results posted: 2012-02-27